Two prospective dosing methods for nortriptyline

Area of Science:

• Pharmacokinetics
• Clinical Pharmacology
• Therapeutic Drug Monitoring

Background:

• Accurate prediction of drug steady-state concentrations is crucial for effective therapeutic drug monitoring.
• Nortriptyline, a tricyclic antidepressant, requires careful dosing to optimize efficacy and minimize toxicity.
• Existing pharmacokinetic dosing methods for nortriptyline vary in complexity and required sampling points.

Purpose of the Study:

• To compare the accuracy of two prospective pharmacokinetic dosing methods for predicting nortriptyline steady-state concentrations.
• To evaluate a single-point prediction method using a 36-hour plasma concentration against a multiple-point method.
• To assess the clinical utility of these dosing protocols.

Main Methods:

• Prospective pharmacokinetic dosing was employed.
• One method involved multiple plasma concentration measurements.
• The second method utilized a single plasma concentration measurement at 36 hours post-dose (NTP 36h) substituted into a linear equation (Cssav = 17.2 + 3.74 (NTP 36h)).

Main Results:

• No significant differences were observed between observed steady-state concentrations (121 +/- 19 ng/ml) and predicted concentrations from both the single-point (121 +/- 21 ng/ml) and multiple-point (122 +/- 19 ng/ml) methods.
• The 36-hour single-point prediction accurately reflected the average steady-state concentration for a 100 mg/day nortriptyline dose.

Conclusions:

• A single plasma concentration measurement at 36 hours is a reliable method for predicting nortriptyline steady-state concentrations.
• This single-point method offers a potentially simpler alternative to multiple-point methods for pharmacokinetic dosing of nortriptyline.
• The study discusses the clinical advantages and disadvantages of each prospective dosing protocol.